J. David Owens
President & CEO
Mr. Owens joined BiologicsMD as Chief Executive Officer in 2013. He brings 30 years of pharmaceutical and biotechnology management and commercialization experience. Mr. Owens was formerly the Chief Business Officer for Novira Therapeutics, Inc., a privately held antiviral drug discovery company were he co-led a syndicated angel investment in 2011 and then a Series A financing in 2012. Prior to Novira, Mr. Owens held executive positions as Senior Vice President, and Business Unit Head of the Surgical Products Division at King Pharmaceuticals (now part of Pfizer) and as Vice President of Global Marketing & Medical Affairs at Aventis Pharma (now part of Sanofi). Earlier in his career, Mr. Owens held commercial operations roles at Genentech, Merck and Abbott Labs. Mr. Owens is a graduate of the University of Wisconsin, School of Pharmacy and a Registered Pharmacist.
Rob Gensure, MD, PhD
Chief Medical Officer
Dr. Rob Gensure joined BiologicsMD as Chief Medical Officer in 2009. He is one of the inventors of the technology and is Chief of Pediatric Endocrinology at Tufts University School of Medicine in Boston. He is board certified in pediatric endocrinology and pediatrics. Dr. Gensure graduated from Tulane University School of Medicine and completed his residency at Massachusetts General Hospital.
Robyn Goforth, PhD
Chief Scientific Officer
Dr. Robyn Goforth joined BiologicsMD as Chief Scientific Officer in 2009. She has over 15 years experience in functional protein design and protein production. She has published over a dozen scientific papers in the fields of biochemistry and bioengineering. Dr. Goforth has also been principal investigator and co-principal investigator on over $10MM in National Institute of Health, Department of Energy, and Small Business Innovation Research grants. She was named in June 2011 one of the top 40 business leaders under 40 by the Arkansas Business Journal.